aMoon Fund

company

About

aMoon is a leading healthtech & life sciences venture capital firm.

  • 11 - 50

Details

Industries
Biotechnology,Health Care,Venture Capital
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Investments

Number of Investments
Number of Lead Investments
9
2
aMoon Fund has made 9 investments. Their most recent investment was on Nov 9, 2022, when Ibex Medical Analytics raised $10M.
Date Company Name
Round Money Raised Industry Lead Investor
Debt Financing $10M Analytics
May 31, 2022 Ultima Genomics
Series Unknown $600M Biotechnology
May 31, 2021 DayTwo
Series B £26.30M Health Care
Mar 23, 2021 Absci
Series Unknown $125M Artificial Intelligence
Series B $38M Analytics